Neutrophil alkaline phosphatase in children with trisomy 21 and their parents

Area of Science:

• Human Genetics
• Biochemistry
• Pediatrics

Background:

• Trisomy 21, commonly known as Down syndrome, is a genetic disorder associated with specific chromosomal abnormalities.
• Neutrophil alkaline phosphatase (NAP) is an enzyme whose levels can be influenced by various physiological and genetic factors.
• Understanding the biochemical markers associated with trisomy 21 can aid in genetic counseling and risk assessment.

Purpose of the Study:

• To comparatively analyze karyotypes and neutrophil alkaline phosphatase (NAP) levels in families with trisomy 21 children versus control families.
• To investigate potential correlations between parental and child NAP levels in trisomy 21 cases.
• To identify any karyotype anomalies in parents of children with trisomy 21.

Main Methods:

• Karyotype analysis was performed on parents and children from both trisomy 21 families and control groups.
• Neutrophil alkaline phosphatase (NAP) levels were measured and compared across all study participants.
• Statistical analysis was employed to determine the significance of observed differences and correlations.

Main Results:

• A statistically significant increase in NAP levels was observed in mothers (P < 10-4), fathers (P < 10-4), and children (P < 10-9) with trisomy 21 compared to controls.
• The NAP level in trisomy 21 affected children was found to be approximately equal to the sum of the NAP levels of their parents (P = 0.80; sigma2 = 5%).
• One parent of a child with trisomy 21 exhibited a karyotype anomaly.

Conclusions:

• Elevated neutrophil alkaline phosphatase (NAP) levels are strongly associated with trisomy 21.
• The additive relationship between parental and child NAP levels in trisomy 21 families suggests a potential genetic or familial predisposition.
• Karyotype analysis remains crucial for identifying chromosomal abnormalities, and NAP levels may serve as a complementary biochemical marker.